Table 1 List of published cases of AST due to Salmonella spp.
Case Number | Publication | Number of Cases | Age& Gender | Predisposing Comorbidities | Thyroid abnormalities | Salmonella Species | Intervention | |
|---|---|---|---|---|---|---|---|---|
Medical | Surgical | |||||||
1 | Svenungsson & Lindberg [17] | 1 | 72 M | Steroid use | N/A | Salmonella enteriditis | TMP-SMX (duration not specified) | None |
2 | Walter and MacMonagle [18] | 1 | 49F | None | MNG | Salmonella choleraesuis | Amoxicillin (duration not specified) | Thyroid lobectomy |
3 | Fule and Saoji [19] | 1 | N/A | N/A | N/A | Salmonella paratyphi A | N/A | N/A |
4 | Nmadu [20] | 2 | N/A | N/A | N/A | Salmonella typhi | N/A | N/A |
5 | Gudipati and Westblom [21] | 1 | 79 M | N/A | N/A | Salmonella typhimurium | Ceftriaxone × 2 weeks | I&D |
6 | Igler, et al. [22] | 1 | 70F | DM | MNG | Salmonella enteritidis | TMP-SMX ×  4 weeks | I&D |
7 | Chiovato, et al. [23] | 1 | 40F | None | MNG | Salmonella Brandenburg | Ceftriaxone × 10 days | Aspiration, I&D, and thyroid lobectomy |
8 | Lalitha and John [24] | 2 | N/A | N/A | None | Salmonella paratyphi A, Salmonella cholerasius | None | None |
9 | Lecuit, et al. [25] | 1 | 48 M | HIV infection | None | Salmonella enteriditis | Amoxicillin × 12 days | I&D |
10 | Susković and Z Vucicević [26] | 1 | 47F | DM | None | Salmonella enteritidis | Antibiotics (not specified) | I&D |
11 | Lala, et al. [27] | 1 | 66 M | None | Thyroid nodule | Salmonella group D | Ciprofloxacin (duration not specified) | Subtotal thyroidectomy |
12 | Jasmi, et al. [14] | 1 | 62F | None | MNG | Salmonella typhi | Amoxicillin-clavulinic acid × 3 days | Aspiration |
13 | Duraker, et al. [7] | 1 | 52 M | DM | None | Salmonella typhi | Netilmicin + Clindamycin (duration not specified) | I&D |
Ofloxacin × 10 days | ||||||||
14 | Su and Huang [16] | 1 | 79F | DM | MNG | Salmonella typhimurium | Ampicillin (duration not specified) | Thyroid lobectomy |
Ceftriaxone × 17 days | ||||||||
Ciprofloxacin (duration not specified) | ||||||||
15 | Dai, et al. [28] | 1 | 82 M | CLL | MNG | Salmonella group B | Ceftriaxone (duration not specified) | I&D |
16 | Sriburee [29] | 1 | 55F | None | MNG | Salmonella group C | TMP-SMX × 2 weeks | Aspiration and I&D |
Cefazolin and metronidazole (duration not specified) | ||||||||
17 | Chen, et al. [30] | 1 | 60F | Invasive thymoma | MNG | Salmonella group D1 | Ceftriaxone × 2 weeks | Thyroid lobectomy |
Oral antibiotics (duration not specified) | ||||||||
18 | Chou and Hsieh [31] | 1 | 31F | None | MNG | Salmonella choleraesuis | Ampicillin/sulbactam | I&D |
Clindamycin and ceftriaxone (duration not specified) | ||||||||
19 | Krudop, et al. [32] | 1 | 53F | None | MNG | Salmonella group C | Antibiotics (duration not specified) | I&D and thyroid lobectomy |
20 | Wu, et al. [1] | 1 | 74 M | Renal transplant on immunosuppressive therapy | None | Salmonella enteriditis | Cefepime × 4 days, | Thyroid lobectomy |
Ceftriaxone × 28 days | ||||||||
Lifelong antibiotics | ||||||||
21 | Ambroziak, et al. [15] | 1 | 82 M | DM, and steroid use | None | Salmonella enteritidis | Ceftriaxone × 2 weeks | Thyroid lobectomy |
Ampicillin × 3 weeks | ||||||||
22 | Kiss, et al. [2] | 1 | 48F | HIV infection | N/A | Salmonella spp. | Ceftriaxone × 2 weeks | I&D |
23 | Kazi, et al. [33] | 1 | 52 M | HIV infection | None | Salmonella spp. | Lifelong TMP-SMX | Thyroid lobectomy |
24 | Kuzu, et al. [9] | 1 | 50F | DM | N/A | Salmonella enteritidis | Metronidazole and ceftriaxone × 5 days | I&D |
Ciprofloxacin × 4 weeks | ||||||||
25 | Murali & Bhandary [5] | 1 | 26F | None | MNG | Salmonella Typhi | Antibiotics × 1 week (duration not specified) | Thyroid lobectomy |
26 | Hernik, et al. [8] | 1 | 61F | DM | None | Salmonella enterica | Clindamycin, ceftazidime × 1 week | I&D |
TMP-SMX ×  1 week | ||||||||
27 | Vengathajalam, et al. [10] | 1 | 58F | DM | MNG | Salmonella spp. | Antibiotics (not specified) | Aspiration |
28 | Quintana, et al. [34] | 1 | N/A | None | N/A | Salmonella enteriditis | Antibiotics (not specified) | None |